• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

苯并[]呋喃衍生物的合成与生物学研究:2011年至2022年综述

Synthesis and Biological Studies of Benzo[]furan Derivatives: A Review from 2011 to 2022.

作者信息

Arce-Ramos Lizeth, Castillo Juan-Carlos, Becerra Diana

机构信息

Escuela de Ciencias Químicas, Universidad Pedagógica y Tecnológica de Colombia, Avenida Central del Norte 39-115, Tunja 150003, Colombia.

出版信息

Pharmaceuticals (Basel). 2023 Sep 6;16(9):1265. doi: 10.3390/ph16091265.

DOI:10.3390/ph16091265
PMID:37765074
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10537293/
Abstract

The importance of the benzo[]furan motif becomes evident in the remarkable results of numerous biological investigations, establishing its potential as a robust therapeutic option. This review presents an overview of the synthesis of and exhaustive biological studies conducted on benzo[]furan derivatives from 2011 to 2022, accentuating their exceptional promise as anticancer, antibacterial, and antifungal agents. Initially, the discussion focuses on chemical synthesis, molecular docking simulations, and both in vitro and in vivo studies. Additionally, we provide an analysis of the intricate interplay between structure and activity, thereby facilitating comparisons and profoundly emphasizing the applications of the benzo[]furan motif within the realms of drug discovery and medicinal chemistry.

摘要

苯并呋喃基序的重要性在众多生物学研究的显著成果中得以彰显,确立了其作为一种强有力治疗选择的潜力。本综述概述了2011年至2022年对苯并呋喃衍生物的合成及详尽的生物学研究,着重强调了它们作为抗癌、抗菌和抗真菌剂的非凡前景。首先,讨论聚焦于化学合成、分子对接模拟以及体外和体内研究。此外,我们分析了结构与活性之间的复杂相互作用,从而便于进行比较并深刻强调苯并呋喃基序在药物发现和药物化学领域的应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/bb0a3f5ad4ab/pharmaceuticals-16-01265-g047.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/eb983d445792/pharmaceuticals-16-01265-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/78d113fea81f/pharmaceuticals-16-01265-g003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/c43b2b1b19d6/pharmaceuticals-16-01265-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/59b57a37dea4/pharmaceuticals-16-01265-sch005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/dd736fa65982/pharmaceuticals-16-01265-g019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/d4bf4b46064d/pharmaceuticals-16-01265-g020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/bc7eb8b3cd21/pharmaceuticals-16-01265-sch009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/7593033dedbe/pharmaceuticals-16-01265-g021.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/a8baaa17dc21/pharmaceuticals-16-01265-sch010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/ba0e6eed5bd1/pharmaceuticals-16-01265-sch011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/78c13bcde7ee/pharmaceuticals-16-01265-g023.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/01767298a12f/pharmaceuticals-16-01265-g024.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/d734e2ede1ef/pharmaceuticals-16-01265-g025.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/edf6a9ab81ae/pharmaceuticals-16-01265-sch014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/92f941a44e4d/pharmaceuticals-16-01265-g027.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/73632ea3ae46/pharmaceuticals-16-01265-g028.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/b50e3530678a/pharmaceuticals-16-01265-sch015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/e3e72ec881e3/pharmaceuticals-16-01265-sch016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/5ce59be30977/pharmaceuticals-16-01265-sch017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/ef3ec18244ad/pharmaceuticals-16-01265-g029.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/89c2179deb8b/pharmaceuticals-16-01265-g031.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/aed351863a79/pharmaceuticals-16-01265-g032.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/0c575a10b7f8/pharmaceuticals-16-01265-sch019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/afc6158ed2a9/pharmaceuticals-16-01265-g033.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/5dd8cb0815b6/pharmaceuticals-16-01265-g034.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/ffb9bc2f3b5d/pharmaceuticals-16-01265-g035.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/27b062818a50/pharmaceuticals-16-01265-g036.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/1f9f19541047/pharmaceuticals-16-01265-g037.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/8750e47fd940/pharmaceuticals-16-01265-g038.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/f8d7620b7de6/pharmaceuticals-16-01265-g039.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/bad3d55b6f7f/pharmaceuticals-16-01265-g042.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/5ea2b82950fa/pharmaceuticals-16-01265-g043.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/d4aa40de7a90/pharmaceuticals-16-01265-sch020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/bb0a3f5ad4ab/pharmaceuticals-16-01265-g047.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/eb983d445792/pharmaceuticals-16-01265-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/78d113fea81f/pharmaceuticals-16-01265-g003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/c43b2b1b19d6/pharmaceuticals-16-01265-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/59b57a37dea4/pharmaceuticals-16-01265-sch005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/dd736fa65982/pharmaceuticals-16-01265-g019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/d4bf4b46064d/pharmaceuticals-16-01265-g020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/bc7eb8b3cd21/pharmaceuticals-16-01265-sch009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/7593033dedbe/pharmaceuticals-16-01265-g021.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/a8baaa17dc21/pharmaceuticals-16-01265-sch010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/ba0e6eed5bd1/pharmaceuticals-16-01265-sch011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/78c13bcde7ee/pharmaceuticals-16-01265-g023.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/01767298a12f/pharmaceuticals-16-01265-g024.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/d734e2ede1ef/pharmaceuticals-16-01265-g025.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/edf6a9ab81ae/pharmaceuticals-16-01265-sch014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/92f941a44e4d/pharmaceuticals-16-01265-g027.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/73632ea3ae46/pharmaceuticals-16-01265-g028.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/b50e3530678a/pharmaceuticals-16-01265-sch015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/e3e72ec881e3/pharmaceuticals-16-01265-sch016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/5ce59be30977/pharmaceuticals-16-01265-sch017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/ef3ec18244ad/pharmaceuticals-16-01265-g029.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/89c2179deb8b/pharmaceuticals-16-01265-g031.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/aed351863a79/pharmaceuticals-16-01265-g032.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/0c575a10b7f8/pharmaceuticals-16-01265-sch019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/afc6158ed2a9/pharmaceuticals-16-01265-g033.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/5dd8cb0815b6/pharmaceuticals-16-01265-g034.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/ffb9bc2f3b5d/pharmaceuticals-16-01265-g035.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/27b062818a50/pharmaceuticals-16-01265-g036.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/1f9f19541047/pharmaceuticals-16-01265-g037.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/8750e47fd940/pharmaceuticals-16-01265-g038.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/f8d7620b7de6/pharmaceuticals-16-01265-g039.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/bad3d55b6f7f/pharmaceuticals-16-01265-g042.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/5ea2b82950fa/pharmaceuticals-16-01265-g043.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/d4aa40de7a90/pharmaceuticals-16-01265-sch020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f13/10537293/bb0a3f5ad4ab/pharmaceuticals-16-01265-g047.jpg

相似文献

1
Synthesis and Biological Studies of Benzo[]furan Derivatives: A Review from 2011 to 2022.苯并[]呋喃衍生物的合成与生物学研究:2011年至2022年综述
Pharmaceuticals (Basel). 2023 Sep 6;16(9):1265. doi: 10.3390/ph16091265.
2
Novel Benzo[B]Furans with Anti-Microtubule Activity Upregulate Expression of Apoptotic Genes and Arrest Leukemia Cells in G2/M Phase.具有抗微管活性的新型苯并[B]呋喃上调凋亡基因的表达并将白血病细胞阻滞在 G2/M 期。
Anticancer Agents Med Chem. 2019;19(3):375-388. doi: 10.2174/1871520619666181122123552.
3
Recent Achievement in the Synthesis of Benzo[b]furans.苯并[b]呋喃的合成新进展。
Curr Org Synth. 2020;17(7):498-517. doi: 10.2174/1570179417666200625212639.
4
Design, synthesis, in vitro and in vivo biological evaluation of 2-amino-3-aroylbenzo[b]furan derivatives as highly potent tubulin polymerization inhibitors.设计、合成、体外和体内生物评价 2-氨基-3-芳酰基苯并[b]呋喃衍生物作为高效的微管聚合抑制剂。
Eur J Med Chem. 2020 Aug 15;200:112448. doi: 10.1016/j.ejmech.2020.112448. Epub 2020 May 12.
5
Novel Danshen methoxybenzo[b]furan derivative antagonizing adipogenic differentiation and production of inflammatory adipokines.新型丹参甲氧基苯并呋喃衍生物拮抗脂肪生成分化和炎症性脂肪因子的产生。
Chem Biol Interact. 2010 Dec 5;188(3):457-66. doi: 10.1016/j.cbi.2010.09.017. Epub 2010 Sep 21.
6
Design, synthesis and structure-activity relationship of 2-(3',4',5'-trimethoxybenzoyl)-benzo[b]furan derivatives as a novel class of inhibitors of tubulin polymerization.设计、合成及 2-(3',4',5'-三甲氧基苯甲酰基)-苯并[b]呋喃衍生物作为新型微管蛋白聚合抑制剂的构效关系研究。
Bioorg Med Chem. 2009 Oct 1;17(19):6862-71. doi: 10.1016/j.bmc.2009.08.027. Epub 2009 Aug 20.
7
Synthesis of 2-, 4- and 5-(2-alkylcarbamoyl-1-methylvinyl)-7-alkyloxybenzo[b]furans and their leukotriene B4 receptor antagonistic activity.2-、4-和5-(2-烷基氨基甲酰基-1-甲基乙烯基)-7-烷氧基苯并[b]呋喃的合成及其白三烯B4受体拮抗活性。
Org Biomol Chem. 2005 Jun 7;3(11):2129-39. doi: 10.1039/b503615a. Epub 2005 May 16.
8
Synthesis of 2-aryl and 3-aryl benzo[b]furan thioethers using aryl sulfonyl hydrazides as sulfenylation reagents.使用芳基磺酰肼作为硫醚化试剂合成2-芳基和3-芳基苯并[b]呋喃硫醚
J Org Chem. 2015 Mar 6;80(5):2918-24. doi: 10.1021/acs.joc.5b00146. Epub 2015 Feb 20.
9
Toluene dioxygenase-catalyzed cis-dihydroxylation of benzo[b]thiophenes and benzo[b]furans: synthesis of benzo[b]thiophene 2,3-oxide.甲苯双加氧酶催化苯并[b]噻吩和苯并[b]呋喃的顺式二羟基化反应:苯并[b]噻吩 2,3-氧化物的合成。
Org Biomol Chem. 2012 Sep 28;10(36):7292-304. doi: 10.1039/c2ob26120k.
10
Copper-promoted hydration and annulation of 2-fluorophenylacetylene derivatives: from alkynes to benzo[b]furans and benzo[b]thiophenes.铜促进的 2-氟苯乙炔衍生物的水合和环化:从炔烃到苯并[b]呋喃和苯并[b]噻吩。
Beilstein J Org Chem. 2014 Dec 4;10:2886-91. doi: 10.3762/bjoc.10.305. eCollection 2014.

引用本文的文献

1
Linking Fluorine with Bio-Derived Furfural: Aiming Towards More Sustainable Fluorinated Polymers and Drugs.将氟与生物衍生糠醛相结合:迈向更可持续的含氟聚合物和药物。
Molecules. 2025 May 24;30(11):2305. doi: 10.3390/molecules30112305.
2
New Benzofuran-Pyrazole-Based Compounds as Promising Antimicrobial Agents: Design, Synthesis, DNA Gyrase B Inhibition, and In Silico Studies.新型苯并呋喃-吡唑类化合物作为有前景的抗菌剂:设计、合成、DNA 回旋酶 B 抑制及计算机模拟研究
Pharmaceuticals (Basel). 2024 Dec 10;17(12):1664. doi: 10.3390/ph17121664.
3
New pyrazolylindolin-2-one based coumarin derivatives as anti-melanoma agents: design, synthesis, dual BRAF/VEGFR-2 inhibition, and computational studies.

本文引用的文献

1
Bioactive 2-pyridone-containing heterocycle syntheses using multicomponent reactions.利用多组分反应合成含生物活性2-吡啶酮的杂环化合物。
RSC Adv. 2022 Dec 7;12(54):34965-34983. doi: 10.1039/d2ra07056a. eCollection 2022 Dec 6.
2
The Anticancer Effects of the Pro-Apoptotic Benzofuran-Isatin Conjugate (5a) Are Associated With p53 Upregulation and Enhancement of Conventional Chemotherapeutic Drug Efficiency in Colorectal Cancer Cell Lines.促凋亡苯并呋喃-异吲哚酮缀合物(5a)对结直肠癌细胞系的抗癌作用与p53上调及传统化疗药物疗效增强相关。
Front Pharmacol. 2022 Aug 15;13:923398. doi: 10.3389/fphar.2022.923398. eCollection 2022.
3
新型基于吡唑并吲哚啉-2-酮的香豆素衍生物作为抗黑色素瘤药物:设计、合成、双重BRAF/VEGFR-2抑制及计算研究
RSC Adv. 2024 Feb 16;14(9):5907-5925. doi: 10.1039/d4ra00157e. eCollection 2024 Feb 14.
4
An Exploration of the Inhibitory Mechanism of Rationally Screened Benzofuran-1,3,4-Oxadiazoles and-1,2,4-Triazoles as Inhibitors of NS5B RdRp Hepatitis C Virus through Pharmacoinformatic Approaches.通过药物信息学方法探索合理筛选的苯并呋喃-1,3,4-恶二唑和-1,2,4-三唑作为丙型肝炎病毒NS5B RdRp抑制剂的抑制机制。
Biomedicines. 2023 Nov 17;11(11):3085. doi: 10.3390/biomedicines11113085.
Recent Applications of the Multicomponent Synthesis for Bioactive Pyrazole Derivatives.
多组分合成在生物活性吡唑衍生物中的最新应用。
Molecules. 2022 Jul 23;27(15):4723. doi: 10.3390/molecules27154723.
4
Prescribed drugs containing nitrogen heterocycles: an overview.含氮杂环的处方药:概述
RSC Adv. 2020 Dec 15;10(72):44247-44311. doi: 10.1039/d0ra09198g. eCollection 2020 Dec 9.
5
Natural source, bioactivity and synthesis of benzofuran derivatives.苯并呋喃衍生物的天然来源、生物活性及合成
RSC Adv. 2019 Sep 2;9(47):27510-27540. doi: 10.1039/c9ra04917g. eCollection 2019 Aug 29.
6
Exploring the Synergistic Anticancer Potential of Benzofuran-Oxadiazoles and Triazoles: Improved Ultrasound- and Microwave-Assisted Synthesis, Molecular Docking, Hemolytic, Thrombolytic and Anticancer Evaluation of Furan-Based Molecules.探索苯并呋喃-恶二唑和三唑的协同抗癌潜力:基于呋喃的分子的超声和微波辅助合成的改进、分子对接、溶血、溶栓和抗癌评估。
Molecules. 2022 Feb 2;27(3):1023. doi: 10.3390/molecules27031023.
7
Discovery of Sortase A covalent inhibitors with benzofuranene cyanide structures as potential antibacterial agents against Staphylococcus aureus.苯并呋喃氰基结构的 sortase A 共价抑制剂的发现,作为抗金黄色葡萄球菌的潜在抗菌剂。
Eur J Med Chem. 2022 Feb 5;229:114032. doi: 10.1016/j.ejmech.2021.114032. Epub 2021 Dec 11.
8
Discovery of Novel Polycyclic Heterocyclic Derivatives from Evodiamine for the Potential Treatment of Triple-Negative Breast Cancer.从吴茱萸碱中发现新型多环杂环衍生物,用于治疗三阴性乳腺癌的潜在药物。
J Med Chem. 2021 Dec 9;64(23):17346-17365. doi: 10.1021/acs.jmedchem.1c01411. Epub 2021 Nov 29.
9
Moracin D induces apoptosis in prostate cancer cells via activation of PPAR gamma/PKC delta and inhibition of PKC alpha.美拉醇诱导前列腺癌细胞凋亡通过激活过氧化物酶体增殖物激活受体 γ / PKC δ 和抑制蛋白激酶 C α。
Phytother Res. 2021 Dec;35(12):6944-6953. doi: 10.1002/ptr.7313. Epub 2021 Oct 28.
10
Structure-Guided Design of a Small-Molecule Activator of Sirtuin-3 that Modulates Autophagy in Triple Negative Breast Cancer.调节三阴性乳腺癌自噬的Sirtuin-3小分子激活剂的结构导向设计
J Med Chem. 2021 Oct 14;64(19):14192-14216. doi: 10.1021/acs.jmedchem.0c02268. Epub 2021 Oct 3.